Biotech stocks like Regeneron (REGN) are rising on speculation there could be a takeover offer for Alexion Pharmaceuticals (ALXN) , according to Jim Cramer. Cramer also commented on reports that the Department of Justice may be filing criminal charges in connection with an investigation into generic drug price collusion, saying that typically in such cases charges are filed against individual company executives and not the corporations themselves. Cramer's Action Alerts PLUS charitable trust holds stock of Allergan (AGN) , which the Wall Street Journal reported is one of the companies being looked at by the Justice Department.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.